Multicenter randomized clinical trial of endovascular treatment for acute ischemic stroke. The effect of periprocedural medication: acetylsalicylic acid, unfractionated heparin, both, or neither (MR CLEAN-MED). Rationale and study design.

Autor: Chalos V; Department of Neurology, Erasmus MC University Medical Center, Rotterdam, The Netherlands.; Department of Radiology & Nuclear Medicine, Erasmus MC University Medical Center Rotterdam, Rotterdam, The Netherlands.; Department of Public Health, Erasmus MC University Medical Center, Rotterdam, The Netherlands., A van de Graaf R; Department of Neurology, Erasmus MC University Medical Center, Rotterdam, The Netherlands.; Department of Radiology & Nuclear Medicine, Erasmus MC University Medical Center Rotterdam, Rotterdam, The Netherlands., Roozenbeek B; Department of Neurology, Erasmus MC University Medical Center, Rotterdam, The Netherlands. b.roozenbeek@erasmusmc.nl.; Department of Radiology & Nuclear Medicine, Erasmus MC University Medical Center Rotterdam, Rotterdam, The Netherlands. b.roozenbeek@erasmusmc.nl., C G M van Es A; Department of Radiology & Nuclear Medicine, Erasmus MC University Medical Center Rotterdam, Rotterdam, The Netherlands., M den Hertog H; Department of Neurology, Isala, Zwolle, The Netherlands., Staals J; Department of Neurology, Cardiovascular Research Institute Maastricht, Maastricht University Medical Center, Maastricht, The Netherlands., van Dijk L; Department of Radiology & Nuclear Medicine, HagaZiekenhuis, Radiology, Den Haag, The Netherlands., F M Jenniskens S; Department of Radiology & Nuclear Medicine, Radboud University Medical Center, Nijmegen, The Netherlands., J van Oostenbrugge R; Department of Neurology, Cardiovascular Research Institute Maastricht, Maastricht University Medical Center, Maastricht, The Netherlands., H van Zwam W; Department of Radiology & Nuclear Medicine, Cardiovascular Research Institute Maastricht, Maastricht University Medical Center, Maastricht, The Netherlands., B W E M Roos Y; Department of Neurology, Amsterdam UMC, University of Amsterdam, location AMC, Amsterdam, The Netherlands., B L M Majoie C; Department of Radiology & Nuclear Medicine, Amsterdam UMC, University of Amsterdam, location AMC, Amsterdam, The Netherlands., F Lingsma H; Department of Public Health, Erasmus MC University Medical Center, Rotterdam, The Netherlands., van der Lugt A; Department of Radiology & Nuclear Medicine, Erasmus MC University Medical Center Rotterdam, Rotterdam, The Netherlands., W J Dippel D; Department of Neurology, Erasmus MC University Medical Center, Rotterdam, The Netherlands.

Publikováno v: Trials [Trials] 2020 Jul 14; Vol. 21 (1), pp. 644. Date of Electronic Publication: 2020 Jul 14.

Antiplatelet Drugs for Neurointerventions: Part 2 Clinical Applications.

Autor: Pearce S; Department of Radiology, Western Health, 160 Gordon St, 3011, Footscray, Victoria, Australia. s.pearce89@gmail.com.; Interventional Neuroradiology Unit, Monash Imaging, Monash Health, Melbourne, Victoria, Australia. s.pearce89@gmail.com., Maingard JT; Interventional Neuroradiology Unit, Monash Imaging, Monash Health, Melbourne, Victoria, Australia.; School of Medicine, Faculty of Health, Deakin University, Waurn Ponds, Victoria, Australia., Kuan Kok H; School of Medicine, Faculty of Health, Deakin University, Waurn Ponds, Victoria, Australia.; Interventional Radiology Service, Northern Health Radiology, Melbourne, Victoria, Australia., Barras CD; South Australian Health and Medical Research Institute, Adelaide, South Australia, Australia.; School of Medicine, The University of Adelaide, Adelaide, South Australia, Australia., Russell JH; Department of Neurosurgery, Austin Health, Melbourne, Victoria, Australia., Hirsch JA; Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA., Chandra RV; Interventional Neuroradiology Unit, Monash Imaging, Monash Health, Melbourne, Victoria, Australia.; Department of Imaging, Monash University, Melbourne, Victoria, Australia., Jhamb A; Interventional Neuroradiology, St Vincent's Hospital, Melbourne, Victoria, Australia., Thijs V; Stroke Division, Florey Institute of Neuroscience and Mental Health, Melbourne, Victoria, Australia.; School of Medicine, University of Melbourne, Melbourne, Victoria, Australia.; Department of Neurology, Austin Health, Melbourne, Victoria, Australia., Brooks M; School of Medicine, Faculty of Health, Deakin University, Waurn Ponds, Victoria, Australia.; Stroke Division, Florey Institute of Neuroscience and Mental Health, Melbourne, Victoria, Australia.; School of Medicine, University of Melbourne, Melbourne, Victoria, Australia.; Interventional Neuroradiology service, Radiology Department, Austin Health, Melbourne, Victoria, Australia., Asadi H; Interventional Neuroradiology Unit, Monash Imaging, Monash Health, Melbourne, Victoria, Australia.; School of Medicine, Faculty of Health, Deakin University, Waurn Ponds, Victoria, Australia.; Stroke Division, Florey Institute of Neuroscience and Mental Health, Melbourne, Victoria, Australia.; School of Medicine, University of Melbourne, Melbourne, Victoria, Australia.; Interventional Neuroradiology service, Radiology Department, Austin Health, Melbourne, Victoria, Australia.

Publikováno v: Clinical neuroradiology [Clin Neuroradiol] 2021 Sep; Vol. 31 (3), pp. 545-558. Date of Electronic Publication: 2021 Mar 01.